Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Otonomy Announces Proposed Public Offering
-
Otonomy to Participate in Three Upcoming Investor Conferences
-
Otonomy Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Otonomy (OTIC) Announces Pricing of $60.1 Million Public Offering of Common Stock, Warrants
-
Otonomy Announces Pricing of $60.1 Million Public Offering
-
Otonomy (OTIC) Commences Public Offering of Common Stock
-
Otonomy Announces Proposed Public Offering
-
Otonomy to Present at Two Upcoming Investor Conferences
-
Otonomy to Participate in Two Upcoming Investor Conferences
-
Otonomy to Present at Cowen and Company Health Care Conference
-
Otonomy (OTIC) PT Lowered to $9 at Cowen Amid Otividex Failure; Dramatic And Fast Changes Needed
-
Otonomy (OTIC): Reiterating Outperform Ahead Of Catalysts - Cowen
-
Otonomy to Present at Cowen and Company Health Care Conference
-
Otonomy to Present at Cowen and Company Health Care Conference
-
Otonomy Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Otonomy (OTIC) Prices 5M Shares at $20
-
Otonomy Announces Pricing of Public Offering of Common Stock
-
Otonomy (OTIC) to Offer $100M in Common Stock
-
Otonomy Announces Proposed Public Offering of Common Stock
-
Otonomy to Present at Two Upcoming Investor Conferences
-
UPDATE: Cowen Starts Otonomy (OTIC) at Outperform
-
Otonomy Announces Closing of Follow-on Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Otonomy (OTIC) Reports $75M Follow-on Public Offering
-
Otonomy Announces Launch of Follow-on Public Offering
-
Otonomy Files Registration Statement for Proposed Follow-on Public Offering

